Stock Events

Stock Events

Search...

Adaptimmune Therapeutics (ADAP) Q2 2024 Earnings

12AugConfirmed

Q3 2023

Q4 2023

Q1 2024

Q2 2024

-0.24

-0.08

0.08

0.24

Details

Expected EPS

-0.08

Actual EPS

0.24

Surprise EPS

0.32

Surprise Percent

+400%

Description

Adaptimmune Therapeutics (ADAP) has reported earnings of 0.24 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.